106 related articles for article (PubMed ID: 23643510)
1. Efficacy of edelfosine lipid nanoparticles in breast cancer cells.
Aznar MÁ; Lasa-Saracíbar B; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
Int J Pharm; 2013 Oct; 454(2):720-6. PubMed ID: 23643510
[TBL] [Abstract][Full Text] [Related]
2. Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines.
Lasa-Saracíbar B; Estella-Hermoso de Mendoza A; Mollinedo F; Odero MD; Blanco-Príeto MJ
Cancer Lett; 2013 Jul; 334(2):302-10. PubMed ID: 23353057
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.
Estella-Hermoso de Mendoza A; Préat V; Mollinedo F; Blanco-Prieto MJ
J Control Release; 2011 Dec; 156(3):421-6. PubMed ID: 21821074
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles protect from edelfosine toxicity in vivo.
Lasa-Saracíbar B; Aznar MÁ; Lana H; Aizpún I; Gil AG; Blanco-Prieto MJ
Int J Pharm; 2014 Oct; 474(1-2):1-5. PubMed ID: 25091376
[TBL] [Abstract][Full Text] [Related]
5. Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles.
Estella-Hermoso de Mendoza A; Campanero MA; Lana H; Villa-Pulgarin JA; de la Iglesia-Vicente J; Mollinedo F; Blanco-Prieto MJ
Nanomedicine (Lond); 2012 May; 7(5):679-90. PubMed ID: 22630151
[TBL] [Abstract][Full Text] [Related]
6. Edelfosine lipid nanoparticles overcome multidrug resistance in K-562 leukemia cells by a caspase-independent mechanism.
Aznar MÁ; Lasa-Saracíbar B; Blanco-Prieto MJ
Mol Pharm; 2014 Aug; 11(8):2650-8. PubMed ID: 24865362
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma.
González-Fernández Y; Brown HK; Patiño-García A; Heymann D; Blanco-Prieto MJ
Cancer Lett; 2018 Aug; 430():193-200. PubMed ID: 29802930
[TBL] [Abstract][Full Text] [Related]
8. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
9. Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model.
Saraiva SM; Gutiérrez-Lovera C; Martínez-Val J; Lores S; Bouzo BL; Díez-Villares S; Alijas S; Pensado-López A; Vázquez-Ríos AJ; Sánchez L; de la Fuente M
Sci Rep; 2021 May; 11(1):9873. PubMed ID: 33972572
[TBL] [Abstract][Full Text] [Related]
10. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK
J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473
[TBL] [Abstract][Full Text] [Related]
11. Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata.
Bhushan S; Kakkar V; Pal HC; Guru SK; Kumar A; Mondhe DM; Sharma PR; Taneja SC; Kaur IP; Singh J; Saxena AK
Mol Pharm; 2013 Jan; 10(1):225-35. PubMed ID: 23237302
[TBL] [Abstract][Full Text] [Related]
12. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization.
Estella-Hermoso de Mendoza A; Rayo M; Mollinedo F; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2008 Feb; 68(2):207-13. PubMed ID: 17707618
[TBL] [Abstract][Full Text] [Related]
16. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems.
Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Príeto MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4035-41. PubMed ID: 19896423
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Marino-Albernas JR; Bittman R; Peters A; Mayhew E
J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells.
González-Fernández Y; Imbuluzqueta E; Zalacain M; Mollinedo F; Patiño-García A; Blanco-Prieto MJ
Cancer Lett; 2017 Mar; 388():262-268. PubMed ID: 27998763
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
Wagner BA; Buettner GR; Oberley LW; Burns CP
Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
